Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • Dynasore: Protocol and QC Guidance for Dynamin GTPase Inhibi

    2026-07-07

    Dynasore: Technical Guidance for Dynamin GTPase Inhibition

    What This Product Solves

    Dynasore (CAS No. 304448-55-3) is a non-competitive inhibitor targeting the dynamin family of GTPases, such as dynamin1, dynamin2, and Drp1. These enzymes are central to membrane fission events, particularly in clathrin-mediated endocytosis and intracellular vesicle trafficking. By reversibly blocking dynamin GTPase activity, Dynasore allows researchers to test the dependency of cellular uptake and vesicle trafficking on dynamin function, supporting investigations in endocytosis research, synaptic vesicle endocytosis inhibition, and signal transduction pathway study. For example, Dynasore is routinely used to prevent transferrin uptake in HeLa cells, providing a direct readout of endocytic inhibition. When protocols require precise, temporal control over endocytic processes or rapid washout of inhibitor, Dynasore’s reversibility and solubility in DMSO make it an actionable tool for dissecting dynamin-dependent pathways.

    For additional context on Dynasore's role in translational research and comparison to alternative inhibitors, see Dynasore and the Future of Endocytosis Research, which discusses its application in vesicle trafficking and disease modeling. For advanced mechanistic detail, Dynasore: Advanced Inhibition of Dynamin-Mediated Endocytosis explores its use in signaling and fungal pathogenicity research.

    Protocol Parameters

    • Assay: Inhibition of dynamin GTPase activity
      Value: IC50 ≈ 15 µM
      Applicability: Use as a starting concentration for in vitro inhibition of dynamin1, dynamin2, and Drp1 in cell culture models.
      Rationale: This value is based on dose-dependent inhibition observed in cellular models as described in the product information.
      Source type: product dossier
    • Assay: Stock solution preparation
      Value: Soluble in DMSO at ≥16.12 mg/mL
      Applicability: Prepare concentrated stocks in DMSO; do not attempt dissolution in water or ethanol.
      Rationale: Ensures complete solubilization, avoids precipitation during dosing.
      Source type: product dossier
    • Assay: Storage conditions
      Value: -20°C for stock solutions; avoid long-term storage of diluted solutions
      Applicability: Store DMSO stocks at -20°C; only prepare working dilutions immediately before use.
      Rationale: Maintains compound integrity and activity, minimizing degradation risk.
      Source type: product dossier
    • Assay: Solubilization technique
      Value: Warming at 37°C or ultrasonic shaking recommended
      Applicability: Apply gentle heat or sonication to assist solubilization during stock preparation.
      Rationale: Promotes rapid and complete dissolution in DMSO.
      Source type: product dossier
    • Assay: Working concentration range
      Value: 10–80 µM (workflow recommendation)
      Applicability: Typical dosing range for cell-based endocytosis inhibition assays.
      Rationale: Enables dose titration to balance efficacy and cytotoxicity; starting at IC50 and adjusting as needed.
      Source type: workflow recommendation

    Workflow Setup and QC Checklist

    • DMSO Stock Preparation: Weigh Dynasore accurately, dissolve in anhydrous DMSO to ≥16.12 mg/mL. If solubility is incomplete, warm to 37°C or apply ultrasound briefly. Inspect for clarity; undissolved material should not be present.
    • Aliquoting and Storage: Aliquot stocks to minimize freeze-thaw cycles. Store at -20°C in tightly sealed vials. Discard stocks showing discoloration or precipitate.
    • Working Solution Freshness: Prepare working dilutions immediately before use. Avoid storing diluted Dynasore, as stability is not guaranteed.
    • Assay Controls: Include DMSO-only controls at matching concentrations to account for solvent effects.
    • Verification of Inhibition: Validate inhibition of endocytosis (e.g., transferrin uptake) in your specific cell system, as potency may vary with cell type and assay conditions.
    • Documentation: Record batch numbers, preparation dates, and storage conditions for traceability.

    Common Failure Modes and Fixes

    • Incomplete solubilization in DMSO: If the compound does not fully dissolve, apply gentle warming (37°C) or brief ultrasonic agitation. Do not add water or ethanol, as Dynasore is insoluble in these solvents.
    • Reduced inhibitory effect: Confirm that the stock is fresh and that the working concentration is appropriate for your assay. Titrate doses if required, and verify cell viability at higher concentrations.
    • Precipitation after dilution: Add Dynasore stock to pre-warmed media slowly with mixing. Avoid high concentrations of DMSO in final working solutions; keep below 0.1–0.2% v/v in cell-based assays.
    • Loss of activity during storage: Use freshly prepared working solutions and avoid repeated freeze-thaw cycles of stocks. Discard any stock solutions that have been stored for extended periods or have undergone multiple freeze-thaws.
    • Solvent toxicity: Ensure DMSO concentrations are compatible with your model system by including solvent-only controls.

    Scope and Limitations

    • Solvent compatibility: Dynasore is only soluble in DMSO, not in water or ethanol. This limits protocol flexibility and may require optimization of solvent concentrations for sensitive cell types.
    • Reversibility: The inhibition of dynamin GTPase activity by Dynasore is reversible and dose-dependent, allowing temporal studies but requiring precise timing and washout steps in experimental design.
    • Specificity boundaries: While Dynasore is characterized as a non-competitive inhibitor of dynamin family GTPases, off-target effects cannot be excluded without additional controls. Its use should be combined with orthogonal validation strategies where specificity is critical.
    • Stability: Working solutions are not stable for long-term storage. Fresh preparation prior to use is necessary to ensure consistent results.
    • Inapplicability for aqueous-only protocols: Avoid use in workflows requiring water-based dissolution or in vivo administration without careful formulation adjustments.

    Conclusion

    Dynasore (SKU A1605) from APExBIO offers reproducible, reversible inhibition of dynamin-mediated endocytosis in cellular models, provided that solubility and handling guidelines are carefully followed. It is particularly useful for dissecting dynamin-dependent processes in endocytosis research, synaptic vesicle endocytosis inhibition, and signal transduction pathway study. For comprehensive technical detail, refer to the product page. Integrating Dynasore into experimental workflows requires strict attention to solubilization, storage, and dosing, as outlined above, to ensure reliable and interpretable results.